Valery M, Tanguy M, Gelli M, Smolenschi C, Hollebecque A, Boileve A
Support Care Cancer. 2024; 32(10):660.
PMID: 39283505
DOI: 10.1007/s00520-024-08807-6.
Yang Y, Zhao B, Gao X, Sun J, Ye J, Li J
J Exp Clin Cancer Res. 2021; 40(1):331.
PMID: 34686205
PMC: 8532307.
DOI: 10.1186/s13046-021-02141-z.
Kang L, Tian Y, Xu S, Chen H
J Neurol. 2020; 268(9):3269-3282.
PMID: 32474658
DOI: 10.1007/s00415-020-09942-w.
Ciampi de Andrade D, Teixeira M, Galhardoni R, Ferreira K, Braz Mileno P, Scisci N
Oncologist. 2017; 22(10):1154-e105.
PMID: 28652279
PMC: 5634769.
DOI: 10.1634/theoncologist.2017-0235.
Starobova H, Vetter I
Front Mol Neurosci. 2017; 10:174.
PMID: 28620280
PMC: 5450696.
DOI: 10.3389/fnmol.2017.00174.
Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?.
Aromolaran K, Goldstein P
Mol Pain. 2017; 13:1744806917714693.
PMID: 28580836
PMC: 5480635.
DOI: 10.1177/1744806917714693.
New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.
Schloss J, Colosimo M, Vitetta L
Asia Pac J Oncol Nurs. 2016; 3(1):73-85.
PMID: 27981142
PMC: 5123533.
DOI: 10.4103/2347-5625.170977.
Interventions for preventing neuropathy caused by cisplatin and related compounds.
Albers J, Chaudhry V, Cavaletti G, Donehower R
Cochrane Database Syst Rev. 2014; (3):CD005228.
PMID: 24687190
PMC: 10891440.
DOI: 10.1002/14651858.CD005228.pub4.
Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors.
Zhu Y, Yang J, Jiao S, Ji T
World J Surg Oncol. 2013; 11:19.
PMID: 23351188
PMC: 3575266.
DOI: 10.1186/1477-7819-11-19.
Effects of calcium and magnesium on acute and chronic neurotoxicity caused by oxaliplatin: A meta-analysis.
Ao R, Wang Y, Li R, Wang Z
Exp Ther Med. 2012; 4(5):933-937.
PMID: 23226752
PMC: 3493795.
DOI: 10.3892/etm.2012.678.
Neuroprotective effect of neurotropin on chronic oxaliplatin-induced neurotoxicity in stage II and stage III colorectal cancer patients: results from a prospective, randomised, single-centre, pilot clinical trial.
Zhang R, Lu Z, Wan D, Wu X, Ding P, Kong L
Int J Colorectal Dis. 2012; 27(12):1645-50.
PMID: 22664945
DOI: 10.1007/s00384-012-1509-4.
Interventions for preventing neuropathy caused by cisplatin and related compounds.
Albers J, Chaudhry V, Cavaletti G, Donehower R
Cochrane Database Syst Rev. 2011; (2):CD005228.
PMID: 21328275
PMC: 3715044.
DOI: 10.1002/14651858.CD005228.pub3.
Oral Calcium Ameliorating Oxaliplatin-Induced Peripheral Neuropathy.
Saif M
J Appl Res. 2009; 4(4):576-582.
PMID: 19816592
PMC: 2758795.
Management of oxaliplatin-induced peripheral neuropathy.
Saif M, Reardon J
Ther Clin Risk Manag. 2008; 1(4):249-58.
PMID: 18360567
PMC: 1661634.
[Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].
Kowalski T, Maier C, Reinacher-Schick A, Schlegel U
Schmerz. 2007; 22(1):16-23.
PMID: 17578604
DOI: 10.1007/s00482-007-0552-5.
Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study.
von Delius S, Eckel F, Wagenpfeil S, Mayr M, Stock K, Kullmann F
Invest New Drugs. 2006; 25(2):173-80.
PMID: 16983507
DOI: 10.1007/s10637-006-9010-y.
Neurologic toxicities of cancer therapies.
Cavaliere R, Schiff D
Curr Neurol Neurosci Rep. 2006; 6(3):218-26.
PMID: 16635431
DOI: 10.1007/s11910-006-0009-8.
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.
Leonard G, Wright M, Quinn M, Fioravanti S, Harold N, Schuler B
BMC Cancer. 2005; 5:116.
PMID: 16168057
PMC: 1266024.
DOI: 10.1186/1471-2407-5-116.
